White label ELPA - ClinicalTrials.eu

Study on the Effectiveness of 2LHERP in Reducing Recurrent Cold Sores in Patients with Frequent Outbreaks

Recruiting

3 1 1
Investigated diseases:
- Herpes simplex
- Oral herpes
Investigated drugs:
Study on the Effectiveness and Safety of Apremilast for Patients Aged 6 and Older with Generalized Epidermolysis Bullosa Simplex

Recruiting

2 1 1 1
Investigated diseases:
- Epidermolysis bullosa
Investigated drugs:
- Apremilast
Study on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis

Recruiting

3 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Rivaroxaban
Study on the Long-Term Effects and Safety of Mirikizumab for Patients with Crohn’s Disease

Recruiting

3 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Mirikizumab
+8
Study of Tranexamic Acid Applied to Surgical Wounds to Prevent Bleeding Complications After Plastic Surgery in Adult Patients

Recruiting

3 1 1
Investigated diseases:
- Post procedural complication
Investigated drugs:
- Tranexamic Acid
- Sodium Chloride
Study on 7-Day vs. 14-Day Antibiotic Treatment for Kidney Infection in Transplant Patients Using Bromhexine Hydrochloride, Trimethoprim, and Fluoroquinolones

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
Study of Oxaliplatin, Nivolumab, and Trifluridine/Tipiracil for Patients with Advanced Gastric, Esophageal, or Gastroesophageal Junction Cancer

Recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:
Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome

Recruiting

3 1
Investigated diseases:
- Lennox-Gastaut syndrome
Investigated drugs:
- Carisbamate
+1
Study on Stopping Rituximab vs. Continuing Rituximab for Patients with ANCA-Associated Vasculitis in Stable Remission

Recruiting

3 1 1 1
Investigated diseases:
- Glomerulonephritis chronic
+1
Study on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years

Recruiting

3 1 1 1
Investigated diseases:
Investigated drugs:
- Rimegepant

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies